Renaissance Technologies »

Rapport Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 35k 29.70
2025-06-30 $177k 16k 11.37

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Kinross Gold Corp (KGC)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Doordash Cl A (DASH)
Hims & Hers Health Com Cl A (HIMS)
Reddit Cl A (RDDT)

View all positions for Renaissance Technologies

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics